Congresswoman Schrier’s legislation would raise awareness around the importance of Type 1 Diabetes screening and start a patient-provider conversation about the risk of developing Type 1 Diabetes and how to identify symptoms. This legislation would specifically: Conduct a public awareness campaign to increase awareness of the signs and symptoms of type 1 diabetes, as well as the importance of early detection and screening.
Expand Type 1 diabetes screening awareness and early detection efforts.
Occurrences
reintroduced the Strengthening Collective Resources for Encouraging Education Needed (SCREEN) for Type 1 Diabetes Act, legislation aimed at raising awareness around the importance of Type 1 Diabetes screening.
Congresswoman Schrier Introduces Bipartisan Legislation to Expand Type 1 Diabetes Screening May 26, 2026 Press Release WASHINGTON, D.C . – Congresswoman Kim Schrier, M.D. (WA-08) , reintroduced the Strengthening Collective Resources for Encouraging Education Needed (SCREEN) for Type 1 Diabetes Act, legislation aimed at raising awareness around the importance of Type 1 Diabetes screening.
Evidence
legacy_unverified · Source version not recorded · locator unknown
GovInfo records H.R. 9000 as introduced by Rep. Kim Schrier on May 21, 2026 and referred to the House Energy and Commerce Committee. The bill would require CDC to run an evidence-based national campaign on type 1 diabetes detection, screening, and management, issue public education materials and PSAs, fund nonprofit and public-health grants, and authorize $5 million annually for FY2027-FY2031.
legacy_unverified · Source version not recorded · locator unknown
CDC published a public-facing type 1 diabetes screening page explaining that high-risk people can benefit from screening before symptoms, that early stages can be identified by screening, how autoantibody blood testing works, and where free screening programs may be available.
Assessments
Schrier made a serious same-term legislative attempt by introducing H.R. 9000 in May 2026 to create a national CDC campaign and grant-supported type 1 diabetes screening and awareness effort. The evidence shows only introduction and committee referral, with no enactment or implemented program attributable to her. A CDC informational screening page shows some related federal awareness activity, but it is limited and not enough to establish that Schrier delivered the promised expansion.